229 related articles for article (PubMed ID: 9874450)
21. [Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase].
Bourel M; Deugnier Y; Brissot P; Leray G; Le Gall JY
Bull Acad Natl Med; 1987 Mar; 171(3):359-64. PubMed ID: 2444315
[No Abstract] [Full Text] [Related]
22. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
23. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
Xing H; Qiu H; Ding X; Han J; Li Z; Wu H; Yan C; Li H; Han R; Zhang H; Li C; Wang M; Wu M; Shen F; Zheng Y; Yang T
Biomark Med; 2019 May; 13(7):545-555. PubMed ID: 31140827
[No Abstract] [Full Text] [Related]
24. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
[TBL] [Abstract][Full Text] [Related]
25. Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
Maringhini A; Cottone M; Sciarrino E; Marcenò MP; La Seta F; Rinaldi F; Pagliaro L
Cancer; 1984 Dec; 54(12):2924-6. PubMed ID: 6208995
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
Zoli M; Magalotti D; Bianchi G; Gueli C; Marchesini G; Pisi E
Cancer; 1996 Sep; 78(5):977-85. PubMed ID: 8780534
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Gan Y; Liang Q; Song X
Tumour Biol; 2014 May; 35(5):3953-60. PubMed ID: 24395655
[TBL] [Abstract][Full Text] [Related]
28. Enhanced detection of hepatocellular carcinoma.
el-Houseini ME; Mohammed MS; Elshemey WM; Hussein TD; Desouky OS; Elsayed AA
Cancer Control; 2005 Oct; 12(4):248-53. PubMed ID: 16258497
[TBL] [Abstract][Full Text] [Related]
29. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
30. [Early diagnosis of hepatocellular carcinoma].
Hirooka N; Matsuura N; Ohto M
Nihon Rinsho; 1994 Jan; 52(1):69-74. PubMed ID: 7509420
[TBL] [Abstract][Full Text] [Related]
31. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
32. False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Mok TS; Yu SC; Lee C; Sung J; Leung N; Lai P; Leung TW; Chan AT; Yeo W; Koh J; Johnson P
AJR Am J Roentgenol; 2004 Aug; 183(2):453-8. PubMed ID: 15269040
[TBL] [Abstract][Full Text] [Related]
33. [Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma].
Zhang SM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):143-6. PubMed ID: 1319891
[TBL] [Abstract][Full Text] [Related]
34. Carbon dots and gold nanoparticles based immunoassay for detection of alpha-L-fucosidase.
Mintz K; Waidely E; Zhou Y; Peng Z; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
Anal Chim Acta; 2018 Dec; 1041():114-121. PubMed ID: 30340683
[TBL] [Abstract][Full Text] [Related]
35. [Surveillance for hepatocellular carcinoma: does it work?].
Kchaou-Ouakaa A; Belhadjbrik N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
Tunis Med; 2007 Oct; 85(10):866-70. PubMed ID: 18236810
[TBL] [Abstract][Full Text] [Related]
36. Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
Anticancer Res; 2001; 21(4B):2979-82. PubMed ID: 11712797
[TBL] [Abstract][Full Text] [Related]
37. Prediction of the development of hepato-cellular-carcinoma in patients with liver cirrhosis by the serial determinations of serum alpha-L-fucosidase activity.
Ishizuka H; Nakayama T; Matsuoka S; Gotoh I; Ogawa M; Suzuki K; Tanaka N; Tsubaki K; Ohkubo H; Arakawa Y; Okano T
Intern Med; 1999 Dec; 38(12):927-31. PubMed ID: 10628928
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients.
Shinagawa T; Ohto M; Kimura K; Tsunetomi S; Morita M; Saisho H; Tsuchiya Y; Saotome N; Karasawa E; Miki M
Gastroenterology; 1984 Mar; 86(3):495-502. PubMed ID: 6198238
[TBL] [Abstract][Full Text] [Related]
39. [Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms].
Cristani A; Borghi A; Cioni G; Vignoli A; Ventura E
Recenti Prog Med; 1992 May; 83(5):286-7. PubMed ID: 1279760
[TBL] [Abstract][Full Text] [Related]
40. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
